A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

Non-alcoholic fatty liver disease (NAFLD) is a growing public health problem worldwide and has become an important field of biomedical inquiry. We aimed to determine whether European countries have mounted an adequate public health response to NAFLD and non-alcoholic steatohepatitis (NASH).

Detalles Bibliográficos
Autores: Lazarus, Jeffrey V., Ekstedt, Mattias, Marchesini, Giulio, Mullen, Jillian, Novak, Katja, Pericàs, Juan M., Roel, Elena, Romero-Gómez, Manuel, Ratziu, Vlad, Tacke, Frank, Cortez-Pinto, Helena, Anstee, Quentin M.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/383923
Acceso en línea:http://hdl.handle.net/10261/383923
https://api.elsevier.com/content/abstract/scopus_id/85074504519
Access Level:acceso abierto
Palabra clave:Europe
Guidelines as topic
Health Policy
Non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic steatohepatitis (NASH)
Review
id ES_62ee6cd2d9e7b0eeeb1d45eb6addcdb7
oai_identifier_str oai:digital.csic.es:10261/383923
network_acronym_str ES
network_name_str España
repository_id_str
spelling A cross-sectional study of the public health response to non-alcoholic fatty liver disease in EuropeLazarus, Jeffrey V.Ekstedt, MattiasMarchesini, GiulioMullen, JillianNovak, KatjaPericàs, Juan M.Roel, ElenaRomero-Gómez, ManuelRatziu, VladTacke, FrankCortez-Pinto, HelenaAnstee, Quentin M.EuropeGuidelines as topicHealth PolicyNon-alcoholic fatty liver disease (NAFLD)Non-alcoholic steatohepatitis (NASH)ReviewNon-alcoholic fatty liver disease (NAFLD) is a growing public health problem worldwide and has become an important field of biomedical inquiry. We aimed to determine whether European countries have mounted an adequate public health response to NAFLD and non-alcoholic steatohepatitis (NASH).Financial support for this research was provided by the EASL International Liver Foundation through grants from Gilead Sciences Europe Ltd., Allergan Pharmaceutical International Ltd., Bristol-Myers-Squibb Company, Pfizer Inc., and Resoundant Inc. JVL is a Miguel Servet-funded researcher at ISGlobal, Hospital Clínic, University of Barcelona. QMA and VR are members of the EPoS (Elucidating Pathways of Steatohepatitis) consortium funded by the Horizon 2020 Framework Program of the European Union under Grant Agreement 634413. QMA, VR, HCP, ME, MRG, HCP are members of the LITMUS (Liver Investigation: Testing Marker Utility in Steatohepatitis) consortium funded by the IMI2 Program of the European Union under Grant Agreement 777377. QMA is a Newcastle NIHR Biomedical Research Centre investigator.Peer reviewedElsevier BVEASL International Liver FoundationBristol-Myers SquibbGilead SciencesEuropean CommissionRomero-Gómez, Manuel [0000-0001-8494-8947]Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202520252020info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/383923https://api.elsevier.com/content/abstract/scopus_id/85074504519reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/EC/H2020/777377https://doi.org/10.1016/j.jhep.2019.08.027Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3839232026-05-22T06:33:51Z
dc.title.none.fl_str_mv A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
title A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
spellingShingle A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, Jeffrey V.
Europe
Guidelines as topic
Health Policy
Non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic steatohepatitis (NASH)
Review
title_short A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
title_full A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
title_fullStr A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
title_full_unstemmed A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
title_sort A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
dc.creator.none.fl_str_mv Lazarus, Jeffrey V.
Ekstedt, Mattias
Marchesini, Giulio
Mullen, Jillian
Novak, Katja
Pericàs, Juan M.
Roel, Elena
Romero-Gómez, Manuel
Ratziu, Vlad
Tacke, Frank
Cortez-Pinto, Helena
Anstee, Quentin M.
author Lazarus, Jeffrey V.
author_facet Lazarus, Jeffrey V.
Ekstedt, Mattias
Marchesini, Giulio
Mullen, Jillian
Novak, Katja
Pericàs, Juan M.
Roel, Elena
Romero-Gómez, Manuel
Ratziu, Vlad
Tacke, Frank
Cortez-Pinto, Helena
Anstee, Quentin M.
author_role author
author2 Ekstedt, Mattias
Marchesini, Giulio
Mullen, Jillian
Novak, Katja
Pericàs, Juan M.
Roel, Elena
Romero-Gómez, Manuel
Ratziu, Vlad
Tacke, Frank
Cortez-Pinto, Helena
Anstee, Quentin M.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv EASL International Liver Foundation
Bristol-Myers Squibb
Gilead Sciences
European Commission
Romero-Gómez, Manuel [0000-0001-8494-8947]
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Europe
Guidelines as topic
Health Policy
Non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic steatohepatitis (NASH)
Review
topic Europe
Guidelines as topic
Health Policy
Non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic steatohepatitis (NASH)
Review
description Non-alcoholic fatty liver disease (NAFLD) is a growing public health problem worldwide and has become an important field of biomedical inquiry. We aimed to determine whether European countries have mounted an adequate public health response to NAFLD and non-alcoholic steatohepatitis (NASH).
publishDate 2020
dc.date.none.fl_str_mv 2020
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/383923
https://api.elsevier.com/content/abstract/scopus_id/85074504519
url http://hdl.handle.net/10261/383923
https://api.elsevier.com/content/abstract/scopus_id/85074504519
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv #PLACEHOLDER_PARENT_METADATA_VALUE#
info:eu-repo/grantAgreement/EC/H2020/777377
https://doi.org/10.1016/j.jhep.2019.08.027
Sí
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier BV
publisher.none.fl_str_mv Elsevier BV
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869409534574854144
score 15,811543

Similares en LA Referencia